We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Healthpeak Properties Inc (DOC) USD1

Sell:$20.39 Buy:$20.40 Change: $0.21 (1.04%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$20.39
Buy:$20.40
Change: $0.21 (1.04%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$20.39
Buy:$20.40
Change: $0.21 (1.04%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT). The Company acquires, develops, owns, leases, and manages healthcare real estate across the United States. Its strategy is to invest in and manage real estate focused on healthcare discovery and delivery. It has a diversified portfolio of high-quality healthcare properties across three core asset classes of lab, outpatient medical, and continuing care retirement community (CCRC) real estate. The Company’s segments include Lab, Outpatient medical and CCRC. The lab segment properties contain laboratory and office space, are leased primarily to biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Outpatient Medical segment includes outpatient medical buildings and hospitals. Outpatient medical buildings typically contain physicians’ offices and examination rooms.

Contact details

Address:
4600 South Syracuse Street, Suite 500
DENVER
80237
United States
Telephone:
+1 (949) 4070700
Website:
https://www.healthpeak.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
DOC
ISIN:
US42250P1030
Market cap:
$14.11 billion
Shares in issue:
699.44 million
Sector:
Health Care REITs
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Scott Brinker
    President, Chief Executive Officer, Director
  • John Thomas
    Vice Chairman of the Board
  • Peter Scott
    Chief Financial Officer
  • Thomas Klaritch
    Chief Operating Officer
  • Lisa Alonso
    Chief Human Resource Officer, Executive Vice President
  • Shawn Johnston
    Executive Vice President, Chief Accounting Officer
  • Ankit Patadia
    Executive Vice President and Treasurer - Corporate Finance
  • Adam Mabry
    Chief Investment Officer
  • Jeffrey Miller
    General Counsel
  • Scott Bohn
    Chief Development Officer and Head of Lab

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.